Bfsg, LLC Edwards Lifesciences Corp Transaction History

Bfsg, LLC

$838 Million
Q4 2024

A detailed history of Bfsg, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Bfsg, LLC holds 6,255 shares of EW stock, worth $440,039. This represents 0.06% of its overall portfolio holdings.

Number of Shares

6,255

Previous 6,255 -0.0%

Holding current value

$440,039

Previous $412,000 12.38%

% of portfolio

0.06%

Previous 0.05%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	SELL	$59.7 - $93.78 $50,148 - $78,775	-840 Reduced 11.84%	6,255 $412,000
Q4 2023 Feb 01, 2024	SELL	$61.71 - $77.76 $18,513 - $23,328	-300 Reduced 4.06%	7,095 $540,000
Q1 2023 May 10, 2023	SELL	$74.26 - $84.51 $75,745 - $86,200	-1,020 Reduced 12.12%	7,395 $612,000
Q4 2022 Feb 01, 2023	SELL	$68.3 - $87.44 $38,384 - $49,141	-562 Reduced 6.26%	8,415 $628,000
Q2 2022 Aug 04, 2022	BUY	$86.5 - $128.27 $776,510 - $1.15 Million	8,977 New	8,977 $854,000
Q1 2022 May 04, 2022	SELL	$101.96 - $128.34 $920,392 - $1.16 Million	-9,027 Closed	0 $0
Q4 2021 Jan 24, 2022	SELL	$106.37 - $130.68 $53,185 - $65,340	-500 Reduced 5.25%	9,027 $1.17 Million
Q3 2021 Nov 03, 2021	BUY	$102.91 - $122.75 $980,423 - $1.17 Million	9,527 New	9,527 $1.08 Million
Q2 2021 Jul 29, 2021	SELL	$83.84 - $104.76 $810,900 - $1.01 Million	-9,672 Closed	0 $0
Q2 2020 Jul 22, 2020	BUY	$57.54 - $76.95 $371,017 - $496,173	6,448 Added 200.0%	9,672 $668,000
Q4 2019 Jan 29, 2020	BUY	$71.7 - $82.09 $231,160 - $264,658	3,224 New	3,224 $752,000
Q3 2018 Oct 18, 2018	SELL	$45.7 - $58.03 $135,591 - $172,175	-2,967 Closed	0 $0
Q2 2018 Jul 31, 2018	BUY	$42.45 - $51.3 $22,668 - $27,394	534 Added 21.95%	2,967 $432,000
Q1 2018 May 08, 2018	BUY	$37.19 - $47.45 $90,483 - $115,445	2,433 New	2,433 $339,000

Others Institutions Holding EW

# of Institutions

1,364

Shares Held

470M

Call Options Held

9.76M

Put Options Held

3.89M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $43.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bfsg, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bfsg, LLC with notifications on news.

Account